a healthy male or female (unable to bear children) 18-55 years of age.
able to meet all eligibility criteria.
able to comply with all study visits.
Compensation: You will be compensated for your time up to $2050.00 for completion of the study.
The Pfizer New Haven Clinical Research Unit is conducting a study of a marketed drug, Naloxone hydrochloride (HCl), used in an emergency for the treatment of a narcotic overdose. It helps to reverse the effects of an overdose, including breathing difficulties.
This study involves: You will be in this study up to about 41 days. This does not include the time between screening and dosing, which can be up to 28 days.
3 dosing periods (during one continuous admission)
6 overnight stays
1 follow-up phone call (between 28 and 35 days after the last dose)